<DOC>
	<DOCNO>NCT01589198</DOCNO>
	<brief_summary>The purpose study learn asthma people well-controlled current asthma medication ( refractory asthma ) . The investigator compare data refractory asthmatic patient National Jewish Health mild asthmatic subject people without asthma . Study experiment involve look sample 3 group compare molecular level . These laboratory experiment may help identify subtypes refractory asthmatic require different treatment .</brief_summary>
	<brief_title>Identification Molecular Biomarkers Stratify Patients With Refractory Asthma</brief_title>
	<detailed_description />
	<mesh_term>Asthma</mesh_term>
	<criteria>Able receive Informed Consent At least 18 year age ICS &lt; 880 mcg ( FP equivalent ) PC20 &lt; =16 mg/mL No 1 oral steroid burst previous 12 month Less 3 urgent care visit previous 12 month No deterioration &lt; =25 % decrease steroids No near fatal asthma event Pregnancy Current smoker , smoke within past year pack/year history &gt; 10 year Respiratory infection within past 6 week Antibiotics within past 6 week Active lung disease asthma Cancer within past 5 year ( exclude basal cell skin cancer ) Active chronic infection Hematological autoimmune disease Unable safely undergo bronchoscopy determine doctor study doctor</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2017</verification_date>
	<keyword>Asthma</keyword>
</DOC>